Merck

  1. Merck pushes forward with osteoporosis drug linked to strokes

    Dicey bone-building pill could be a heart-stopper

    Imagine it's the 1870s and you and the family are working the homestead in some Midwestern prairie town.

    That's when a traveling snake oil salesman set up shop in the village square and unloads the worst sales pitch you've ever heard. He tells you his miracle tonic won't regrow your hair or loosen up that balky knee -- heck, he admits it may even kill you.

    Then he tries to sell it to you for $100 a bottle.

    And if that sounds crazier than having your shoes shined in a dust storm, then you'll be sorry you missed a recent Merck shareholders meeting. Because a drug company scientist violated Big Pharma's first rule of business.

    He told the truth. He admitted Merck's new drug is a would-be killer -- and they're going to try to sell it to you anyway.

    Merck, which rakes in a cool $48 billion a year off your misery, has announced it's going to plow ahead and seek FDA approval for its potentially dangerous osteoporosis drug odanacatib. And odanacatib will strengthen your bones alright -- in fact, you may have the finest looking skeleton in the cemetery.

    That's because even Merck's top researcher is admitting that the drug has been found to cause strokes and atrial fibrillation -- a rare and possibly deadly irregular heartbeat -- among folks in clinical trials.

    But Merck has poured MILLIONS into developing drugs like odanacatib, and I imagine your life is worth a heck of a lot less to them than that.

    This isn't some outrage -- it's the new normal. Big Pharma is bringing DOZENS of potentially deadly drugs to market each year, practically daring the cowards at the FDA to reject them.

    But like an unemployed mason, Uncle Sam just doesn't have the stones. If you want to keep your bones rock solid as you age, try natural supplements like magnesium that are great for your bones AND your heart.

    But skip Merck's latest wonder cure. Because it's a potential killer... and that smiling carnival barker trying to sell you a bottle knows it.

  2. Medical school admins on drug company payrolls

    Medical school leaders swimming in Big Pharma cash

    We've been calling for reform. We've been calling for an end to the war on natural medicine, so tomorrow's doctors could learn to treat their patients with the safest, most effective therapies available.

    But if we really want to fix medical education in this country, it turns out there's something else we should have been calling for all along.

    An exterminator.

    Because an appalling new study out of Pittsburgh proves that America's medical schools are infested with stinking rats masquerading as administrators, accepting MILLIONS in dirty Big Pharma cash.

    And when you hear how many of them are doing it, you're going to be madder than a wet hen.

    A team from the University of Pittsburgh studied the 50 largest drug companies selling in the U.S. market, and found that 47 of them had board members that were also serving in major leadership roles at U.S. medical schools. We're talking university presidents, deans... you name it.

    These university hotshots are deciding the future of medical education from their ivory towers -- but it would appear those towers have drug-company logos painted on the sides. In fact, the medical schools administrators are racking in, ON AVERAGE, $312,564 a year in Big Pharma cash.

    It takes just three years to become a millionaire on a Big Pharma board, and you'd better believe that money comes with more strings than the New York Philharmonic Orchestra!

    Listen, I've been telling you for years that Big Pharma works so hard to influence medical education in America that they'd have you write your first prescription on the back of your diploma if they could.

    The researchers, who are probably just hours from being slapped with drug company subpoenas, were careful to point out that they're not accusing any administrators or drug companies of anything illegal. And they're right -- it's not against the law in the United States for a medical school administrator to serve on a drug company board.

    But just because it's legal doesn't make it right. And it's time we put those donkeys in Congress... those folks who are SUPPOSED to represent our best interests... to work ending this disgusting practice once and for all.

    Find your member of Congress here, and tell him it's high time we passed a law banning medical school administrators from serving on Big Pharma boards.

    Because there ought to be more to medical education in America than listening to drug company sales pitches. And you ought to be able to walk into any university president's office and not catch him puffing a cigar as he counts stacks of dirty money with some Big Pharma rep at his side.

  3. Big Pharma "speaking fees" creating medical millionaires

    Find out if your doctor is accepting cash from major drug companies.
  4. Major news organization blames parents for unborn child's death

    It's a new low, even for the flu vaccine crowd. One of mainstream medicine's vaccination cheerleaders (aka a major news organization) is playing politics with a dead baby and sick Arkansas mom, as they once again refuse to admit the abysmal failure rate of the nearly useless flu vaccine.
  5. Potentially dangerous drug on fast track for approval

    Merck's potentially deadly blood thinning drug vorapaxar was left for dead after disastrous clinical trials, but now it's getting new life thanks to an FDA panel stocked with drug company insiders. Is the FDA about to approve a drug that's been linked to serious internal bleeding and could be a killer for stroke patients?
  6. Virginia is for mandates

    Parents have spoken loud and clear: They don't want dangerous HPV vaccinations forced on their daughters. Even the most ardent pro-vaccine moms and dads have been refusing Merck's Gardasil shot, and I say good for them.
  7. Don't trust new Gardasil 'study'

    You'd have to be on the Merck payroll to believe the company's dangerous HPV vaccine is actually safe. And sure enough, the latest study to make that claim was funded by none other than Merck itself.
  8. The two-in-one med that's double the trouble

    Diabetics, you know the score: The more pills you take... the sicker you get. Well, now Merck wants to "help." They're cutting back on the number of pills -- but don't get too excited: They're not actually reducing the number of drugs.
  9. Researchers: Merck knew – and did nothing

    A new analysis published in the Archives of Internal Medicine concludes that Merck had enough warning signs to pull this bad med from the market nearly FOUR YEARS before they actually did.
  10. Merck pays medical associations to promote Gardasil

    The news about Gardasil keeps getting worse. A report has recently come to light revealing that docs from as many as three respected medical associations accepted money from Merck to promote this dangerous and unnecessary vaccine.

Items 1 to 10 of 25 total

Page: